JAMES STOCKTON: Open Payments
NPI 1487016267 · SHEBOYGAN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 61 payments from 11 companies in 2025. Trend: 2023 $1,189 · 2024 $1,569 · 2025 $1,241
Food & beverage: $1,241
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $262 |
| Alkermes, Inc. | 11 | $251 |
| Lundbeck LLC | 12 | $237 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| E.R. Squibb & Sons, L.L.C. | 5 | $100 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
Products named: ARISTADA, AUSTEDO XR, ABILIFY ASIMTUFII, REXULTI, ABILIFY MAINTENA, COBENFY, UZEDY, FANAPT.
Industry payments across WI — which companies pay providers there.
